Elastography in Patients With Idiopathic Inflammatory Myopathies

Sponsor
Benha University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03897803
Collaborator
(none)
80
1
18.6
4.3

Study Details

Study Description

Brief Summary

The aim of our study was to assess the performance of compression-strain US elastography in patients with idiopathic inflammatory myopathies over time and to study these findings with clinical and functional parameters as well as biochemical and electromyographic tests.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: strain elastography

Detailed Description

This study will be carried out on four groups:

Group (I): twenty children diagnosed to have idiopathic inflammatory myopathies(IIM)

  • Group (II): twenty adults diagnosed to have IIM

  • Group (III):20 healthy children matching age and sex as first control group to children with IIM .

  • Group (VI):20 healthy adults matching age and sex as second control group to adults with IIM.

All patients will be evaluated at baseline at & 4-months follow up using Semi-Quantitative strain elastography

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Elastography as a Follow up Imaging Tool in Patients With Idiopathic Inflammatory Myopathies
Actual Study Start Date :
Apr 15, 2019
Anticipated Primary Completion Date :
Nov 1, 2020
Anticipated Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Group (I):juvenile dermatomyositis (JDM)

Group (I): twenty children diagnosed to have juvenile dermatomyositis (JDM) Who will be evaluated using using strain elastography to assess muscle stiffness at baseline and after 4 months. .

Diagnostic Test: strain elastography
strain elastography as apart of muscle ultrasound examination of the biceps brachii and rectus femoris muscles will be performed to the patients and control groups at baseline evaluation and after 4 months follow up in the patients groups only.

Group (II):idiopathic inflammatory myopathies(IIM)

Group (II): twenty adults diagnosed to have idiopathic inflammatory myopathies(IIM) Who will be evaluated using using strain elastography to assess muscle stiffness at baseline and after 4 months. •

Diagnostic Test: strain elastography
strain elastography as apart of muscle ultrasound examination of the biceps brachii and rectus femoris muscles will be performed to the patients and control groups at baseline evaluation and after 4 months follow up in the patients groups only.

Group (III): juvenile control group

20 healthy children matching age and sex as first control group to children with JDM .Who will be evaluated at baseline using using strain elastography to assess muscle stiffness . .

Diagnostic Test: strain elastography
strain elastography as apart of muscle ultrasound examination of the biceps brachii and rectus femoris muscles will be performed to the patients and control groups at baseline evaluation and after 4 months follow up in the patients groups only.

Group (VI):adult control group

20 healthy adults matching age and sex as second control group to adults with IIM. Who will be evaluated at baseline using using strain elastography to assess muscle stiffness .

Diagnostic Test: strain elastography
strain elastography as apart of muscle ultrasound examination of the biceps brachii and rectus femoris muscles will be performed to the patients and control groups at baseline evaluation and after 4 months follow up in the patients groups only.

Outcome Measures

Primary Outcome Measures

  1. Manual muscle testing [6 months]

    Kendall's 0 -10 point scale measures strength of each muscle group score 0 is the weakest (worst) and 10 is the strongest (best). The following muscles were tested bilaterally: the biceps brachii muscle (BB), the forearm flexors(FF), the rectus femoris muscle (RF), the tibialis anterior muscle (TA)

  2. Serum creatine kinase (CK) levels [6 months]

    CK measured in U/L using ELISA

  3. Serum Lactate dehydrogenase (LDH) levels [6 months]

    LDHmeasured in IU/L using ELISA

  4. alanine aminotransferase (ALT) [6 months]

    ALT measured in U/L using ELISA

  5. Aspartate aminotransferase (AST) [6 months]

    AST measured in U/L using ELISA

  6. motor unit potential (MUP) duration [6 months]

    quantitative electromyography (QEMG) in the most affected rectus femoris and biceps brachii muscles will be performed and The motor unit potentials will be reviewed offline for the needle-detected EMG signals will be analyzed by the device software for the MUP duration measured in milliseconds.

  7. motor unit peak-to-peak amplitude [6 months]

    quantitative electromyography (QEMG) in the most affected rectus femoris and biceps brachii muscles will be performed and The motor unit potentials will be reviewed offline for the needle-detected EMG signals will be analyzed by the device software for the peak-to-peak amplitude measured in microvolt

  8. motor unit area to amplitude ratio (AAR) [6 months]

    quantitative electromyography (QEMG) in the most affected rectus femoris and biceps brachii muscles will be performed and The motor unit potentials will be reviewed offline for the needle-detected EMG signals will be analyzed by the device software for the motor unit AAR .

  9. muscle echo intenisity (EI) [6 MONTHS]

    EI is assessed during muscle ultrasound evaluation means of computer-assisted grayscale histogram analysis of Adobe Photoshop . echo intensity was calculated based on a histogram analysis which expresses every pixel as a value between 0 (black) and 255 (white)..he following muscles were tested bilaterally: the biceps brachii muscle (BB), the forearm flexors(FF), the rectus femoris muscle (RF), the tibialis anterior muscle (TA)

  10. Childhood myositis assessment scale [6 months]

    used to assess the severity of muscle involvement in children with dermatomyositis. The scores for the 14 items are summated to give a total score ranging from 0 (worst) to 52 (best)

  11. MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL (MDAAT) [6 months]

    The MDAAT is a combined tool that includes the Myositis Disease Activity Assessment visual analog scale (VAS) (MYOACT) and the Myositis Intention to Treat Activities Index (MITAX).it Assesses 6 extramuscular organs to produce a global extramuscular score, and the muscle score, which gives a total disease activity index score. Scores range from 0-60 for the extramuscular MYOACT score and 0-70 for the total MYOACT score, and they range from 0-54 for the Extramuscular MITAX score and 0-63 for the total MITAX score. higher scores indicates worse outcome

  12. CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE (CHAQ) [6 months]

    There are 30 items in the Disability Index; one item each in the Discomfort Index and Health Status Index. Score range. The range is 0-3. Higher scores reflect greater disability.

  13. HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) [6months]

    20 questions grouped into eight subscales (dressing and grooming, arising, eating, walking, hygiene, reach, grip, activities). (score = 0 to 3 with higher score means worse outcome ). The highest score for any question determines the score for the subscale in question. The HAQ disability index is calculated as the sum of the scores for various subscales,divided by the number of subscales responded to, and results in a score between 0 and 3. higher score means worse outcome

  14. MYOSITIS DAMAGE INDEX (MDI) [6months]

    The MDI measures specific manifestations in 11 organ systems The MDI also includes a series of visual analog scales (VAS) to quantify damage severity in a given organ system. The VAS are summed together for a potential score of 0-110 with higher scores has worse prognosis

  15. PHYSICIAN GLOBAL ACTIVITY assessment [6 months]

    visual analogue scale rating, a score of 0-10 (down to 1 decimal place) is used, higher score means worse outcome

  16. PATIENT/PARENT GLOBAL ACTIVITY assessment [6 months]

    visual analogue scale rating, a score of 0-10 (down to 1 decimal place) is used, higher score means worse outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • to fulfill criteria of diagnosis of childhood and adult idiopathic inflammatory myopathies
Exclusion Criteria:
  • Patients with age less than 2 years were excluded from the study due to inability to perform manual muscle testing and functional scales.

  • The presence of a associated illness that may result in nerve or muscle affection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Benha University Hospital Banhā Qalubiya Egypt 13518

Sponsors and Collaborators

  • Benha University

Investigators

  • Principal Investigator: Waleed A Hassan, MD, Benha university- Qaluibya- Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Waleed Ahmed Salaheldeen Hassan, Assistant professor, Benha University
ClinicalTrials.gov Identifier:
NCT03897803
Other Study ID Numbers:
  • BenhaU2022019
First Posted:
Apr 1, 2019
Last Update Posted:
Oct 19, 2020
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2020